Astrid L.H.M.W. van Lier

Heidelberg University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Astrid L.H.M.W. van Lier is a pioneering researcher at the intersection of medical robotics and interventional oncology, with a primary focus on advancing precision in prostate cancer treatment. Her work centers on the development and clinical translation of robotic systems for MR-guided high-dose-rate (HDR) brachytherapy, a critical technique for delivering targeted radiation to tumors while sparing healthy tissue. In her landmark proof-of-concept study, "ROBiNSon," Dr. van Lier demonstrated the feasibility of robotic needle implantation for HDR brachytherapy, achieving remarkable spatial accuracy for single intraprostatic targets. This work, published in 2024, represents a significant leap forward in automating complex, image-guided interventions, potentially reducing procedure time and improving treatment consistency. While her citation count is still growing, the novelty and clinical relevance of her research have already positioned her as a key voice in the field of robotic-assisted interventional radiology. Her contributions are paving the way for more precise, less invasive cancer therapies, making her a researcher to watch in the rapidly evolving landscape of precision oncology and medical robotics.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Heidelberg University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago